GCG and Glucose intolerance: Additionally, an approach utilizing a Gi-coupled designer receptor exclusively activated by designer drugs (to lower glucagon secretion from the α-cell showed that a significant loss of plasma glucagon levels coincided with a drop in plasma insulin and glucose intolerance in an intraperitoneal glucose tolerance test (IPGTT) (85).